Healthcare costs, insurance barriers, and medical debt are preventing patients with chronic illnesses in the US from ...

Steffen Lang, president, operations, executive committee member, Novartis, shares strategic insights on how pharma supply chain leaders can elevate operations to drive innovation, growth, and patient ...

In the third part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Kimberly Westrich, chief strategy officer at the National Pharmaceutical Council, details the aspect of her ...

White G. Rethinking Your C&GT Value Chain: How to Ensure Readiness for Evolving Specialized Therapy Requirements. April 9, ...

Respective industry and government agendas could significantly reshape the US prescription drug market.

“To move at speed, you need to partner with people that are better than you.” This was just one of several memorable quotes ...

In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Rachel Thorpe, executive director at ...

A panel discussion breaks down ways for stakeholders to meet temperature-controlled operational demands pertaining to product ...

Ensuring that essential treatments reach patients safely and efficiently is an increasing imperative in today's pharma landscape.

How data-driven insights can help pharma companies balance their revenue management and innovation strategies—including ...

New facility is expected to serve as a global hub for accelerating the development of next-generation antibody-drug ...

Steffen Lang, president, operations, executive committee member, Novartis, discusses the premise of a keynote session on reimagining operations.